JP2020515248A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515248A5
JP2020515248A5 JP2019552004A JP2019552004A JP2020515248A5 JP 2020515248 A5 JP2020515248 A5 JP 2020515248A5 JP 2019552004 A JP2019552004 A JP 2019552004A JP 2019552004 A JP2019552004 A JP 2019552004A JP 2020515248 A5 JP2020515248 A5 JP 2020515248A5
Authority
JP
Japan
Prior art keywords
mouse
trem2p
apoe4p
genetically modified
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019552004A
Other languages
English (en)
Japanese (ja)
Other versions
JP7623785B2 (ja
JP2020515248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/023565 external-priority patent/WO2018175581A1/en
Publication of JP2020515248A publication Critical patent/JP2020515248A/ja
Publication of JP2020515248A5 publication Critical patent/JP2020515248A5/ja
Priority to JP2023023328A priority Critical patent/JP2023056032A/ja
Application granted granted Critical
Publication of JP7623785B2 publication Critical patent/JP7623785B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019552004A 2017-03-21 2018-03-21 ヒトAPOE4およびマウスTrem2 p.R47Hを発現する遺伝子改変されたマウス、ならびにその使用の方法 Active JP7623785B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023023328A JP2023056032A (ja) 2017-03-21 2023-02-17 ヒトAPOE4およびマウスTrem2 p.R47Hを発現する遺伝子改変されたマウス、ならびにその使用の方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762474358P 2017-03-21 2017-03-21
US62/474,358 2017-03-21
PCT/US2018/023565 WO2018175581A1 (en) 2017-03-21 2018-03-21 A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 MOUSE Trem2.p.R47H AND METHODS OF USE THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023023328A Division JP2023056032A (ja) 2017-03-21 2023-02-17 ヒトAPOE4およびマウスTrem2 p.R47Hを発現する遺伝子改変されたマウス、ならびにその使用の方法

Publications (3)

Publication Number Publication Date
JP2020515248A JP2020515248A (ja) 2020-05-28
JP2020515248A5 true JP2020515248A5 (https=) 2021-04-22
JP7623785B2 JP7623785B2 (ja) 2025-01-29

Family

ID=63586166

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019552004A Active JP7623785B2 (ja) 2017-03-21 2018-03-21 ヒトAPOE4およびマウスTrem2 p.R47Hを発現する遺伝子改変されたマウス、ならびにその使用の方法
JP2023023328A Ceased JP2023056032A (ja) 2017-03-21 2023-02-17 ヒトAPOE4およびマウスTrem2 p.R47Hを発現する遺伝子改変されたマウス、ならびにその使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023023328A Ceased JP2023056032A (ja) 2017-03-21 2023-02-17 ヒトAPOE4およびマウスTrem2 p.R47Hを発現する遺伝子改変されたマウス、ならびにその使用の方法

Country Status (7)

Country Link
US (2) US11957115B2 (https=)
EP (1) EP3599842B1 (https=)
JP (2) JP7623785B2 (https=)
CN (1) CN110891417B (https=)
AU (1) AU2018239433B2 (https=)
CA (1) CA3057289A1 (https=)
WO (1) WO2018175581A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
US20210195879A1 (en) * 2018-06-21 2021-07-01 The Jackson Laboratory Genetically modified mouse models of alzheimer's disease
WO2023015153A2 (en) * 2021-08-02 2023-02-09 President And Fellows Of Harvard College ANTISENSE OLIGONUCLEOTIDE TARGETING APOE ε4 AND USES THEREOF
CN114731987B (zh) * 2022-05-19 2023-06-23 华芯微鱼(苏州)生物科技有限公司 颅缝早闭症小鼠模型、其构建方法及应用
CN115536734B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-丙-缬-亮-亮肽及制备方法
CN116103292B (zh) * 2022-11-25 2024-01-30 首都医科大学宣武医院 Zdhhc21基因突变动物模型的构建方法及其应用
CN119234771A (zh) * 2024-09-13 2025-01-03 广东省人民医院 一种帕金森病认知障碍小鼠模型的构建方法与应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356802A (en) 1992-04-03 1994-10-18 The Johns Hopkins University Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
US5436150A (en) 1992-04-03 1995-07-25 The Johns Hopkins University Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
US5487994A (en) 1992-04-03 1996-01-30 The Johns Hopkins University Insertion and deletion mutants of FokI restriction endonuclease
EP0788546B9 (en) 1994-10-18 2007-06-13 Dendreon Corporation Nematode-extracted serine protease inhibitors and anticoagulant proteins
CN1206421A (zh) * 1995-11-01 1999-01-27 科斯药品公司 载脂蛋白e2和阿尔采默氏病的治疗
US6175057B1 (en) * 1997-10-08 2001-01-16 The Regents Of The University Of California Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy
US6046381A (en) 1998-04-30 2000-04-04 The Regents Of The University Of California Apolipoprotein E transgenic mice and assay methods
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
JP2001017028A (ja) * 1999-05-06 2001-01-23 Mitsubishi Chemicals Corp アポeヒト化哺乳動物
EP1063298A3 (en) 1999-06-04 2001-03-28 Glaxo Group Limited Transgenic Animal Model for Alzheimer Disease
US6830910B1 (en) 1999-07-21 2004-12-14 Albert Einstein College Of Medicine Of Yeshiva University Drosophila recombination-associated protein and methods for use
IL147345A0 (en) 1999-07-21 2002-08-14 Einstein Coll Med Drosphila recombination- associated protein and methods for use
US20060167227A1 (en) * 2002-07-12 2006-07-27 Axon Neuroscience Forschungs-Und Entwicklungs Gmbh Truncated tau proteins
JP2005534710A (ja) 2002-08-07 2005-11-17 ノバルティス アクチエンゲゼルシャフト Apoe遺伝子型を基準とした痴呆を処置するための方法
US20070134796A1 (en) 2005-07-26 2007-06-14 Sangamo Biosciences, Inc. Targeted integration and expression of exogenous nucleic acid sequences
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
EP1907566A4 (en) 2005-05-27 2008-12-10 Memory Pharm Corp VECTORS FOR TRANSGENIC MORBUS ALZHEIMER MOUSE MODEL AND USES THEREOF
EP2027262B1 (en) 2006-05-25 2010-03-31 Sangamo Biosciences Inc. Variant foki cleavage half-domains
JP4942081B2 (ja) 2006-06-20 2012-05-30 独立行政法人理化学研究所 アルツハイマー病モデル動物およびその用途
WO2010002982A1 (en) * 2008-07-01 2010-01-07 Cognosci, Inc. Methods of treating cancer with apoe peptides
CA2735578C (en) * 2008-08-12 2018-10-23 Zinfandel Pharmaceuticals, Inc. Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors
WO2013181618A2 (en) * 2012-05-31 2013-12-05 The Trustees Of Columbia University In The City Of New York Methods to treat alzheimer's disease using apoe inhibitors
WO2014074942A1 (en) 2012-11-08 2014-05-15 Illumina, Inc. Risk variants of alzheimer's disease
CN109641961A (zh) * 2016-07-22 2019-04-16 德国神经退行性疾病研究中心 Trem2切割调节剂及其用途
US20210195879A1 (en) 2018-06-21 2021-07-01 The Jackson Laboratory Genetically modified mouse models of alzheimer's disease
US20220099659A1 (en) 2019-01-23 2022-03-31 The Regents Of The University Of California Human Genomic Construct Reporter Cells and Mouse Models to Screen Therapeutics against Microglia-expressed Disease Associated Genes
EP4262372A4 (en) 2020-12-16 2024-11-20 The Jackson Laboratory A genetically modified immunodeficient mouse expressing human or humanized app and mutated human psen1

Similar Documents

Publication Publication Date Title
JP2020515248A5 (https=)
Dathe et al. Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2
Logan et al. Species specificity in major urinary proteins by parallel evolution
JP2017514501A5 (https=)
JP2009148257A5 (https=)
JP2015523863A5 (https=)
Hughes et al. Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling
JP2017213006A5 (https=)
JP2011087580A5 (https=)
Guo et al. Genome reference and sequence variation in the large repetitive central exon of human MUC5AC
Grochowska et al. Effects of intronic SNPs in the myostatin gene on growth and carcass traits in colored Polish merino sheep
Bai et al. A nucleotide substitution in the ovine KAP20-2 gene leads to a premature stop codon that affects wool fibre curvature
Matuszek et al. Base editing of trinucleotide repeats that cause Huntington’s disease and Friedreich’s ataxia reduces somatic repeat expansions in patient cells and in mice
JP2019511918A5 (https=)
Fontanesi Rabbit genetic resources can provide several animal models to explain at the genetic level the diversity of morphological and physiological relevant traits
WO2018175581A8 (en) A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE Trem2 p.R47H AND METHODS OF USE THEREOF
IL319209A (en) Non-human animals containing a humanized ASGR1 locus
JP2019505216A5 (https=)
Arslan et al. Analysis of structural variation among inbred mouse strains
Duan et al. Polymorphisms in ion transport genes are associated with eggshell mechanical property
Sakamoto et al. Delineation of genomic deletion in cardiomyopathic hamster
Deshpande et al. ZNF423 patient variants, truncations, and in-frame deletions in mice define an allele-dependent range of midline brain abnormalities
JP2017500888A5 (https=)
JP2018512842A5 (https=)
JP2008505626A5 (https=)